109 filings
Page 2 of 6
8-K
suzwdqaw090r21t454
15 May 18
SteadyMed Provides Corporate Update and Reports First Quarter 2018 Financial Results
12:59pm
8-K
d2m2h4t9 j09h
30 Apr 18
Entry into a Material Definitive Agreement
6:32am
DEFA14A
txvb od8aej
30 Apr 18
Additional proxy soliciting materials
6:32am
DEFA14A
uqx54bx
30 Apr 18
Additional proxy soliciting materials
6:30am
8-K
st1kjjykwh 5cttjg5
30 Mar 18
SteadyMed Provides Corporate Update and Reports Fourth Quarter and Full Year 2017 Financial Results
12:00am
8-K
wswjzv239wm21d2wfv
4 Jan 18
Submission of Matters to a Vote of Security Holders
12:00am
8-K
n78am101
13 Nov 17
SteadyMed Reports Third Quarter 2017 Financial Results and Provides Corporate Update
12:00am
8-K
1s1dwr c4
5 Sep 17
Steadymed Receives Refusal to File Letter from Fda for Trevyent® New Drug Application
12:00am
8-K
q3i1j
11 Aug 17
SteadyMed Reports Second Quarter 2017 Financial Results and Provides Corporate Update
12:00am
EFFECT
e5vlvwr9k1efewespdvk
6 Jun 17
Notice of effectiveness
12:00am
CORRESP
negm8
5 Jun 17
Correspondence with SEC
12:00am
UPLOAD
kn726 cm7yyr
2 Jun 17
Letter from SEC
12:00am
8-K
se3i oaox19a4dklhqdy
12 May 17
SteadyMed Reports First Quarter 2017 Financial Results and Provides Corporate Update
12:00am